Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1010-1017
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1010
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1010
Table 1 Reverse transcription polymerase chain reaction primers
Gene name | Primer sequence | Product length, bp |
Fas | forward: 5′-GAATGCAAGGGACTGATAGC-3′ | 414 |
Reverse: 5′-TGGTTCGTGTGCAAGGCTC-3′ | ||
FasL | forward: 5′-GGAATGGGAAGACACATATGGAACTGC-3′ | 239 |
Reverse: 5′-CATATCTGGCCAGTAGTGCAGTAATT-3′ | ||
Caspase-3 | forward: 5′-GCTATTGTGAGGCGGTTGT-3′ | 270 |
Reverse: 5′-CGTTTGGAGTCCCTTTGT-3′ | ||
Caspase-8 | forward: 5′-TCTGGAGCATCTGCTGTCTG-3′ | 427 |
Reverse: 5′-TTGACGTCTGTGGTCCGTCC-3′ | ||
p53 | forward: 5′-CTTTCAACTCTGTCTCCTTC-3′ | 180 |
Reverse: 5′-TGGGCAACCAGCCCTGTCGT-3′ | ||
Bcl-2 | forward: 5′-CAGCTGCACCTGACGCCCTT-3′ | 231 |
Reverse: 5′-GCCTCCGTTATCCTGGATCC-3′ | ||
β-actin | forward: 5′-ACACTGTGCCCATCTACGAGG-3′ | 621 |
Reverse: 5′-AGGGGCCGGACTCGTCATACT-3′ |
Table 2 Comparison of the inhibition rates of proliferation of hepatocellular carcinoma SMMC-7721 cells in the groups with different Solanum lyratum Thumb concentrations, -x ± s
Group | Concentration, mg/L | n | OD value | Inhibition rate, % |
Three ST groups with different concentrations | 2.5 | 12 | 1.516 ± 0.205 | 18.22 ± 2.32 |
5 | 12 | 1.242 ± 0.236 | 36.56 ± 2.51 | |
10 | 12 | 0.815 ± 0.276 | 55.98 ± 3.12 | |
Negative control group | 0 | 12 | 1.842 ± 0.183 | - |
Positive control group | 2.5 | 12 | 1.135 ± 0.172 | 38.60 ± 1.78 |
Table 3 Comparison of apoptosis rates of hepatocellular carcinoma SMMC-7721 cells in different groups, -x ± s
Group | Concentration, C/mg•L-1 | Apoptosis rate of SMMC-7721 cells, % |
Three ST groups with different concentrations | 2.5 | 10.75 ± 2.51 |
5 | 17.31 ± 2.33 | |
10 | 30.21 ± 3.62 | |
Negative control group | 0 | 3.75 ± 1.23 |
Positive control group | 2.5 | 17.36 ± 1.62 |
Table 4 mRNA expressions of genes relating to hepatocellular carcinoma SMMC-7721 cells in each group
Group | Concentration, C/mg•L-1 | mRNA expression of genes | ||||||
Fas | FasL | Caspase-8 | Caspase-3 | p53 | Bcl-2 | β-actin | ||
Three ST groups with different concentrations | 2.5 | 52.47 ± 0.10 | 58.25 ± 0.51 | 30.57 ± 0.10 | 22.15 ± 0.02 | 34.17 ± 0.01 | 36.28 ± 0.14 | 17.53 ± 0.14 |
5 | 52.74 ± 0.08 | 56.81 ± 0.30 | 30.76 ± 0.03 | 22.33 ± 0.09 | 34.45 ± 0.20 | 35.40 ± 0.51 | 18.15 ± 0.41 | |
10 | 53.41 ± 0.64 | 55.94 ± 0.80 | 31.30 ± 0.24 | 23.01 ± 0.47 | 35.11 ± 0.69 | 33.54 ± 0.51 | 19.10 ± 0.91 | |
Negative control group | 0 | 52.32 ± 0.04 | 59.13 ± 0.07 | 30.44 ± 0.06 | 22.05 ± 0.03 | 34.11 ± 0.02 | 37.59 ± 0.33 | 17.30 ± 0.17 |
Positive control group | 2.5 | 52.79 ± 0.11 | 56.69 ± 0.34 | 30.77 ± 0.03 | 22.35 ± 0.12 | 34.43 ± 0.20 | 35.53 ± 0.35 | 18.18 ± 0.41 |
Table 5 Differences in mRNA expressions of genes relating to hepatocellular carcinoma SMMC-7721 cells in each group
Group | Concentration, C/mg•L-1 | 2-ΔΔCT | |||||
Fas | FasL | Caspase-8 | Caspase-3 | p53 | Bcl-2 | ||
Negative control group | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Three ST groups with different concentrations | 2.5 | 1.06 ± 0.06 | 2.30 ± 0.93a | 1.08 ± 0.04 | 1.10 ± 0.12 | 1.13 ± 0.11 | 3.09 ± 0.59a |
5 | 1.34 ± 0.25a | 9.02 ± 0.32b | 1.47 ± 0.31a | 1.50 ± 0.27a | 1.43 ± 0.16a | 9.46 ± 0.58b | |
10 | 1.63 ± 0.14a | 31.34 ± 0.13b | 2.02 ± 0.71a | 1.82 ± 0.40a | 1.75 ± 0.25a | 47.29 ± 0.68b | |
Positive control group | 5 | 1.33 ± 0.17a | 10.02 ± 0.57b | 1.49 ± 0.30a | 1.50 ± 0.19a | 1.47 ± 0.11a | 8.92 ± 0.09b |
- Citation: Mo XQ, Wei HY, Huang GR, Xu LY, Chen YL, Qi J, Xian W, Qin YC, Wei LD, Zhao LJ, Huang YQ, Xing W, Pu HQ, Wei PY, Li CG, Liang QC. Molecular mechanisms of apoptosis in hepatocellular carcinoma cells induced by ethanol extracts of Solanum lyratum Thumb through the mitochondrial pathway. World J Gastroenterol 2017; 23(6): 1010-1017
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1010.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1010